Rainier Investment Management LLC increased its position in shares of Teleflex Inc. (NYSE:TFX) by 121.0% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 72,010 shares of the medical technology company’s stock after buying an additional 39,430 shares during the period. Rainier Investment Management LLC owned approximately 0.16% of Teleflex worth $12,768,000 at the end of the most recent quarter.

Several other hedge funds also recently made changes to their positions in TFX. Vanguard Group Inc. boosted its stake in shares of Teleflex by 10.2% in the second quarter. Vanguard Group Inc. now owns 3,322,782 shares of the medical technology company’s stock worth $589,162,000 after buying an additional 306,432 shares during the period. Atlanta Capital Management Co. L L C boosted its stake in shares of Teleflex by 3.1% in the second quarter. Atlanta Capital Management Co. L L C now owns 1,888,221 shares of the medical technology company’s stock worth $334,801,000 after buying an additional 57,226 shares during the period. BlackRock Institutional Trust Company N.A. boosted its stake in shares of Teleflex by 7.0% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 1,282,744 shares of the medical technology company’s stock worth $227,443,000 after buying an additional 83,801 shares during the period. State Street Corp boosted its stake in shares of Teleflex by 6.3% in the second quarter. State Street Corp now owns 1,160,615 shares of the medical technology company’s stock worth $205,788,000 after buying an additional 69,298 shares during the period. Finally, Wellington Management Group LLP boosted its stake in shares of Teleflex by 120.7% in the first quarter. Wellington Management Group LLP now owns 761,800 shares of the medical technology company’s stock worth $119,610,000 after buying an additional 416,696 shares during the period. 93.98% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Teleflex Inc. (NYSE:TFX) traded up 0.06% during midday trading on Friday, hitting $143.07. The stock had a trading volume of 562,289 shares. Teleflex Inc. has a 1-year low of $125.28 and a 1-year high of $188.79. The stock has a market capitalization of $6.30 billion, a PE ratio of 24.71 and a beta of 0.88. The stock’s 50-day moving average is $159.01 and its 200-day moving average is $169.81.

Teleflex (NYSE:TFX) last issued its earnings results on Thursday, October 27th. The medical technology company reported $1.80 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.78 by $0.02. The business earned $455.60 million during the quarter, compared to the consensus estimate of $461.80 million. Teleflex had a return on equity of 15.66% and a net margin of 15.09%. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.60 earnings per share. On average, equities research analysts anticipate that Teleflex Inc. will post $7.30 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 15th. Shareholders of record on Tuesday, November 15th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Thursday, November 10th. This represents a $1.36 dividend on an annualized basis and a yield of 0.95%. Teleflex’s payout ratio is currently 23.49%.

A number of analysts recently issued reports on the company. Zacks Investment Research cut Teleflex from a “hold” rating to a “sell” rating in a research note on Tuesday, November 1st. Leerink Swann increased their target price on Teleflex from $183.00 to $190.00 and gave the stock a “market perform” rating in a research note on Friday, July 29th. Stephens cut Teleflex from an “overweight” rating to an “equal weight” rating in a research note on Friday, October 28th. Jefferies Group increased their target price on Teleflex from $157.00 to $185.00 and gave the stock a “hold” rating in a research note on Friday, July 29th. Finally, Barclays PLC increased their target price on Teleflex from $183.00 to $185.00 and gave the stock an “overweight” rating in a research note on Friday, July 29th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average price target of $171.33.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company markets and sells its products to hospitals and healthcare providers, across the world, through a combination of its direct sales force and distributors.

5 Day Chart for NYSE:TFX

Receive News & Stock Ratings for Teleflex Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Inc. and related stocks with our FREE daily email newsletter.